Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.39
+0.57 (7.29%)
At close: Mar 13, 2026, 4:00 PM EDT
8.40
+0.01 (0.12%)
After-hours: Mar 13, 2026, 7:59 PM EDT

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8,6262,0032,1833,3682,1372,419
Market Cap Growth
313.06%-8.26%-35.17%57.57%-11.64%-52.53%
Enterprise Value
9,2282,5962,8163,9792,7492,743
Last Close Price
8.391.982.565.025.076.08
PE Ratio
--5.21-4.13-4.37-4.87-6.83
PS Ratio
76.1417.68148.085414.408905.652589.73
PB Ratio
--4.00-4.46-5.74-4.78-9.99
P/TBV Ratio
-15.42-3.64-3.67-4.35-4.53-9.77
P/FCF Ratio
--6.49-5.48-8.48-5.14-7.85
P/OCF Ratio
--6.57-5.58-9.18-6.33-8.81
EV/Sales Ratio
81.4522.92190.966397.4911453.342936.41
EV/EBITDA Ratio
--10.80-8.62-11.58-8.25-8.68
EV/EBIT Ratio
--10.14-8.18-10.98-7.82-8.30
EV/FCF Ratio
--8.41-7.07-10.01-6.61-8.91
Debt / Equity Ratio
-1.67-1.67-1.60-1.50-1.60-2.63
Debt / EBITDA Ratio
-3.50-3.50-2.41-2.57-2.17-2.04
Debt / FCF Ratio
-2.73-2.73-1.98-2.22-1.74-2.10
Net Debt / Equity Ratio
-1.20-1.20-1.31-1.05-1.38-1.36
Net Debt / EBITDA Ratio
-2.49-2.49-1.96-1.79-1.85-1.04
Net Debt / FCF Ratio
-1.94-1.94-1.60-1.55-1.48-1.07
Asset Turnover
0.260.260.030.000.000.00
Inventory Turnover
0.160.160---
Quick Ratio
4.624.622.774.610.220.86
Current Ratio
5.105.103.365.050.280.91
Return on Equity (ROE)
71.17%71.17%77.02%112.74%120.31%193.07%
Return on Assets (ROA)
-57.85%-57.85%-77.57%-83.58%-84.53%-95.70%
Return on Invested Capital (ROIC)
-130.88%-130.88%-185.09%-191.44%-249.77%-397.87%
Return on Capital Employed (ROCE)
-66.66%-66.66%-88.92%-235.48%1820.67%-260.92%
Earnings Yield
-4.07%-19.19%-24.22%-22.91%-20.51%-14.64%
FCF Yield
-3.58%-15.42%-18.23%-11.80%-19.45%-12.73%
Buyback Yield / Dilution
-19.90%-19.90%-8.46%-3.18%-2.80%-6.86%
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q